Most benzodiazepines are detectable in urine for 1 to 5 days after the last dose, but long-acting types can show up for 10 to 30 days. High doses taken over a long period can extend that window to roughly 6 weeks. The exact timeframe depends on which benzodiazepine you took, how often you used it, and your body’s metabolism.
Detection Times by Type
Benzodiazepines fall into three categories based on how quickly your body processes them, and each category has a different detection window in urine.
- Short-acting (triazolam, midazolam): 1 to 3 days
- Intermediate-acting (alprazolam, lorazepam, temazepam): 1 to 5 days
- Long-acting (diazepam, clonazepam): up to 10 days for a single or short-term use, up to 30 days with regular use
Diazepam is the biggest outlier. Your liver converts it into a secondary compound called nordiazepam, which lingers in the body far longer than the original drug. This is why someone who takes diazepam regularly can test positive weeks after stopping. According to data from the American Academy of Family Physicians, high doses of any benzodiazepine can produce a positive result for up to 6 weeks.
What Affects How Long They Stay Detectable
The ranges above are averages. Your personal detection window shifts based on several factors.
Dose and frequency. A single low dose clears faster than weeks of daily use. With repeated dosing, the drug and its byproducts accumulate in your body’s fat tissue, creating a reservoir that slowly releases back into your bloodstream and eventually your urine. Someone who took one alprazolam tablet at a party faces a very different timeline than someone who has been taking it daily for months.
Body composition. Benzodiazepines are fat-soluble, meaning they get stored in body fat and released gradually. People with a higher body fat percentage tend to retain these compounds longer. Age plays a role here too: metabolism generally slows as you get older, and body composition shifts toward more fat and less muscle.
Liver function. Your liver does the heavy lifting in breaking down benzodiazepines. Anything that impairs liver function, whether it’s liver disease, alcohol use, or certain medications competing for the same processing pathways, can slow clearance. Genetic differences also matter. Some people are naturally fast metabolizers, while others are slow, and this variation can meaningfully shift detection times in either direction.
Hydration and kidney function. Since the test measures what’s in your urine, how concentrated your urine is on the day of testing matters. Dehydration produces more concentrated urine, which makes detection more likely near the tail end of a detection window. That said, drinking large amounts of water won’t reliably clear the drug faster; it just dilutes the sample, which labs can flag as inconclusive.
How Urine Tests Actually Work
Standard urine drug screens use a method called immunoassay. It works by detecting a group of compounds rather than identifying one specific drug. When the test comes back positive, it means the total concentration of benzodiazepine-related compounds in your sample exceeded a preset threshold, typically 200 or 300 ng/mL depending on the lab.
This approach has a significant blind spot. Immunoassay tests are designed around older benzodiazepines like diazepam and its metabolites. They perform poorly with certain commonly prescribed benzodiazepines. Lorazepam and clonazepam, for example, are known to produce false negatives on standard screening tests. Mayo Clinic Laboratories data shows that the concentration of lorazepam’s metabolite would need to be nearly 200 times the cutoff level to trigger a positive result on some immunoassay platforms. This means someone actively taking lorazepam could test negative.
When a more precise answer is needed, labs use a technique called liquid chromatography with mass spectrometry (LC-MS/MS). This confirmatory test identifies individual benzodiazepines and their specific metabolites at much lower concentrations. It’s far more accurate but also more expensive and slower to process, so it’s typically reserved for confirming or clarifying an initial screening result.
One-Time Use vs. Regular Use
If you took a single dose of a short- or intermediate-acting benzodiazepine, you’re generally looking at a detection window of 1 to 5 days. For most people in this situation, the drug will be undetectable within 3 to 4 days.
Regular use changes the picture dramatically. When you take benzodiazepines daily for weeks or months, the drug accumulates in your tissues faster than your body can eliminate it. Long-acting types like diazepam and chlordiazepoxide are especially prone to this buildup because their active metabolites have half-lives measured in days, not hours. In chronic users, 30 days is a reasonable estimate for long-acting benzodiazepines, and 6 weeks is possible at high doses.
Even intermediate-acting drugs like alprazolam can extend their detection window with chronic use. Someone taking alprazolam three times daily for several months may test positive for a week or more after their last dose, compared to the 2 to 3 days expected from a single tablet.
Why Results Sometimes Seem Wrong
Unexpected drug test results with benzodiazepines are common enough that they have their own body of clinical literature. A few scenarios explain most surprises.
A positive result weeks after stopping usually means the benzodiazepine was long-acting or used heavily. The metabolites stored in fat tissue continue leaching out slowly. This is especially true for diazepam, where the active metabolite nordiazepam can circulate for weeks.
A negative result while actively taking a benzodiazepine is most often a testing limitation. Standard immunoassay screens simply miss certain drugs, particularly lorazepam and clonazepam. If your test result doesn’t match your actual use, the type of test matters as much as the timing. A confirmatory LC-MS/MS test will give a far more accurate picture.